http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102288246-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 |
| filingDate | 2017-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102288246-B1 |
| titleOfInvention | Mechanical targets of rapamycin signaling pathway inhibitors and their therapeutic applications |
| abstract | The present disclosure relates to selective mTOR inhibitors of formulas (I) to (III), methods for their preparation, pharmaceutical compositions containing them, and diseases resulting from abnormal cell growth, function or behavior mediated by mTOR kinase and/or one or more PI3K enzymes and Provided is their use in the treatment of a disorder. Such diseases and disorders include cancer, immune disorders, cardiovascular diseases, viral infections, inflammation, metabolic/endocrine dysfunction and neurological disorders. |
| priorityDate | 2016-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 217.